Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Citi upgrades Intuitive Surgical to Buy as market volatility eases, with Stryker placed on a 90-day catalyst watch an...
Citi issued a life sciences sector note that elevates Agilent Technologies while reducing Icon PLC’s target, signalin...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
Trump's remarks on a major U.S. refinery milestone vault the energy complex into the spotlight, with Marathon Petrole...
Analysts raise the oracle price target $240 after Oracle reports resilient AI cloud demand and stronger-than-expected...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
Serve Robotics beats Q4 revenue estimates, lifts 2026 guidance to roughly 10x 2025 levels, and gains credibility from...
A caller earning $140K on The Dave Ramsey Show exposes how discretionary debt can erode cash flow, underscoring a bro...
Revolut has begun launching its UK bank after a regulator lifted license restrictions. The phased migration will roll...
Bitcoin surged toward $71k and then cooled near $70k as geopolitical headlines about Iran dominated market sentiment,...
Mastercard unveiled a sweeping Crypto Partner Program that brings together Ripple, Binance, PayPal and dozens more to...